CPDC was founded by Dr. John Valliant of McMaster University in 2008 as a Centre of Excellence for Commercialization and Research (CECR), specializing in radiopharmaceutical research and development. CPDC’s mission is to improve the quality of Canadian patients’ lives through the commercialization of advanced research and the clinical development of nuclear medicine.
Nuclear Medicine for all Canadians
Our website uses cookies to ensure you get the best experience. Learn more about the policy.